ARQ 197, a novel and selective inhibitor of the human c-Met receptor tyrosine kinase with antitumor activity. [electronic resource]
- Molecular cancer therapeutics Jun 2010
- 1544-53 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1538-8514
10.1158/1535-7163.MCT-09-1173 doi
Animals Apoptosis--drug effects Caspases--metabolism Cell Line, Tumor Cell Proliferation--drug effects Humans Immunosuppression Therapy Mice Mice, Nude Neoplasms--enzymology Phosphorylation--drug effects Protein Kinase Inhibitors--chemistry Proto-Oncogene Mas Proto-Oncogene Proteins c-met--antagonists & inhibitors Pyrroles--chemistry Pyrrolidinones--chemistry Quinolines--chemistry Signal Transduction--drug effects Xenograft Model Antitumor Assays